[翻译文章] 关于慢性患者的药物坚持和相关因素的验证问卷:系统性审查
Aldana Intilangelo1, Sofía Majic1, Valeria Palchik1
1Área Farmacia Asistencial, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario, Argentina.
概括
这一系统性审查确定了14个经过验证的问卷,用于评估慢性疾病成年人的药物坚持. 其中六个问卷已经在西班牙语中得到验证,为医疗保健专业人员提供工具.
科学领域:
- 药理学和制药科学 药理学和制药科学
- 公共卫生和流行病学
- 临床医学 临床医学
背景情况:
- 药物坚持对于管理慢性病理至关重要.
- 需要有效的工具来评估遵守及其影响因素.
- 现有的文献缺乏西班牙语中可用的问卷的全面概述.
研究的目的:
- 系统地确定验证的调查问卷来评估药物服药.
- 为了确定与慢性疾病成年患者的药物坚持相关的因素.
- 为了特别找到在西班牙语中验证的问卷.
主要方法:
- 对PubMed和Scopus数据库的系统审查 (2022年5月).
- 搜索策略结合了"药物坚持"与"问卷"和"验证",包括"西班牙语".
- 包括西班牙语或英语的全文文章 (2000年1月至2022年4月),并引用参考文献,遵循PRISMA指南.
主要成果:
- 确定了14个经过验证的药物坚持性问卷.
- 这些问卷评估了合规性和相关因素 (障碍/促进因素).
- 在西班牙语中验证了六个问卷,其中一些是针对某些慢性病理的.
结论:
- 有14个经过验证的问卷可用于全面评估药物坚持.
- 其中六个是西班牙语验证的,适用于医院和社区药房服务.
- 该审查使卫生专业人员能够适应或开发适合当地环境的问卷.
相关概念视频
Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Factors Influencing Drug Absorption: Disease States and Pharmacology
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications


